What Iterative Health and Gastroenterology Associates of New Jersey Announced About Their Research Partnership
Iterative Health said on 8 July 2026 that it had become the research partner of Gastroenterology Associates of New Jersey, and that two research sites had been newly established at the practice in Toms River and Clifton, New Jersey. The announcement describes the group as having 28 locations and more than 60 healthcare professionals, says further sites across the network are under active discussion, and says the practice joins a global network of more than 110 Iterative Health sites. George Pavlou, chief executive of Gastroenterology Associates of New Jersey, is quoted saying the partnership gives the practice the infrastructure to offer patients access to the therapies that will define the next generation of treatment. Jonathan Ng, chief executive of Iterative Health, is quoted describing a deliberate strategy to create the most capable community based research network in the field. No financial terms are stated.
Why the Iterative Health and GANJ Research Partnership Matters to Trial Sponsors and Patients
The reason this kind of deal keeps happening is arithmetic. Trials need patients, patients are mostly in community practices, and community practices have no way to run a study. Whoever solves that gets to sell sponsors something they genuinely cannot buy elsewhere, and the patient who gets offered a trial in Toms River instead of being told to drive to a city hospital is the real gain. Read the numbers carefully, though. Twenty eight locations is the practice; two is the number of research sites that now exist. Everything else is described as under discussion, which is not the same as signed. The 110 site network figure is also the company counting its own sites, with no way to tell how many are actively enrolling. The honest version of this story is that a large practice has started, not that a large practice has converted.
Where the Iterative Health Update Comes From
Iterative Health is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.
Iterative Health original source.
How We Would Research the Iterative Health and GANJ Research Partnership
The source gives us the starting point. This is how we would build the next layer of research around it.
- We would start by asking how many of the 28 locations can offer a patient a trial today, because two sites and a network are different promises.
- Then we would ask both parties who pays for the research coordinators inside the practice, since that cost usually decides whether a community site survives its first year.
- We would look for a sponsor that placed a study at Toms River or Clifton, because a site with no study is a room.